PBH
Prestige Consumer Healthcare Inc
Price:  
75.13 
USD
Volume:  
565,155.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PBH EV/EBITDA

49.3%
Upside

As of 2025-07-19, the EV/EBITDA ratio of Prestige Consumer Healthcare Inc (PBH) is 12.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PBH's latest enterprise value is 4,629.76 mil USD. PBH's TTM EBITDA according to its financial statements is 374.46 mil USD. Dividing these 2 quantities gives us the above PBH EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 11.0x - 15.7x 11.8x
Forward P/E multiples 18.3x - 29.5x 23.8x
Fair Price 65.10 - 195.42 112.17
Upside -13.4% - 160.1% 49.3%
75.13 USD
Stock Price
112.17 USD
Fair Price

PBH EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-18 12.44
2025-07-17 12.36
2025-07-16 12.37
2025-07-15 12.37
2025-07-14 12.53
2025-07-11 12.54
2025-07-10 12.68
2025-07-09 12.86
2025-07-08 12.82
2025-07-07 12.86
2025-07-03 13.00
2025-07-02 13.03
2025-07-01 13.05
2025-06-30 12.99
2025-06-27 13.13
2025-06-26 13.16
2025-06-25 13.24
2025-06-24 13.62
2025-06-23 13.59
2025-06-20 13.46
2025-06-18 13.49
2025-06-17 13.49
2025-06-16 13.49
2025-06-13 13.53
2025-06-12 13.68
2025-06-11 13.68
2025-06-10 13.88
2025-06-09 13.76
2025-06-06 13.67
2025-06-05 13.62
2025-06-04 13.64
2025-06-03 13.65
2025-06-02 13.73
2025-05-30 13.75
2025-05-29 13.60
2025-05-28 13.58
2025-05-27 13.78
2025-05-23 13.77
2025-05-22 13.67
2025-05-21 13.59
2025-05-20 14.00
2025-05-19 14.19
2025-05-16 14.21
2025-05-15 13.94
2025-05-14 13.72
2025-05-13 13.93
2025-05-12 14.07
2025-05-09 13.97
2025-05-08 13.94
2025-05-07 13.19